I agree, the rails already exist and are operationally more cost effective to leverage in any go to market strategy. No concern bringing in expertise who knows how to navigate these waters. I've invested in too many companies that have failed to commercialise product because they've underestimated how difficult it is to build a distribution funnel.
Ann: Leading pharmaceutical executive to be appointed as Chairman, page-5
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
| BOD (ASX) Chart |
Day chart unavailable